跳转至内容
Merck
CN

I17451

异烟酰胺

ReagentPlus®, 99%

别名:

吡啶-4-甲酰胺

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C6H6N2O
化学文摘社编号:
分子量:
122.12
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
215-926-2
Beilstein/REAXYS Number:
2173
MDL number:
Assay:
99%
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI

1S/C6H6N2O/c7-6(9)5-1-3-8-4-2-5/h1-4H,(H2,7,9)

InChI key

VFQXVTODMYMSMJ-UHFFFAOYSA-N

SMILES string

NC(=O)c1ccncc1

product line

ReagentPlus®

assay

99%

mp

155-157 °C (lit.)

Quality Level

正在寻找类似产品? 访问 产品对比指南

Application

异烟酰胺(吡啶-4-甲酰胺)可作为合成以下物质的杂环结构单元:
  • 潜在抗结核剂4-氧代-1,3-噻嗪烷-3-基异烟酰胺衍生物。
  • 通过合成氨基磷酸酯配体制备的用于各种生物活性研究的异烟酰胺有机锡 (IV) 复合物。
  • 2-(羟基亚氨基)-N-(吡啶-3-基)乙酰胺的双吡啶鎓异烟酰胺衍生物,其是一种强效活化剂沙林

它还可用作共晶试剂(co-former),与活性药物成分(API)一起制备共晶体。

Legal Information

ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

New organotin (IV) complexes of nicotinamide, isonicotinamide and some of their novel phosphoric triamide derivatives: Syntheses, spectroscopic study and crystal structures
Gholivand K, et al.
Journal of Organometallic Chemistry, 695(9), 1383-1391 (2010)
QSAR, docking studies of 1, 3-thiazinan-3-yl isonicotinamide derivatives for antitubercular activity
Chitre TS, et al.
Computational Biology and Chemistry, 68, 211-218 (2017)
Y Zhu et al.
Acta biomaterialia, 5(9), 3346-3357 (2009-05-23)
Shape memory polyurethane (SMPU) ionomers containing constant 75 wt.% soft segment content were synthesized using poly(epsilon-caprolactone)diol, 4,4'-diphenylmethane diisocyanate, 1,4-butanediol and/or N,N-bis(2-hydroxyethyl)-isonicotinamide. To introduce substrate bonding antibacterial activity, pyridinium was prepared through a neutralization reaction using 1-iodooctane as neutralization agent. For
Yan Li et al.
European journal of pharmacology, 609(1-3), 13-18 (2009-03-17)
The phytoalexin resveratrol has been described to have chemopreventive and chemotherapeutic effects in several tumor models while its effects on osteosarcoma have not been extensively studied. Additionally, resveratrol is a potent activator of the Sirt1/Sir2 (silent information regulator 2) family
Jinjing Li et al.
Chemical communications (Cambridge, England), 47(5), 1530-1532 (2010-11-23)
For each of the well-known co-crystal formers, isonicotinamide and nicotinamide, a new polymorph, obtained during attempted co-crystallisation experiments, has been fully characterized and its stability relationship with previously reported forms established.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持